Major Cancer Breakthrough:
Please see 60 minutes for the news report or go to Duke University and review Information for the Clinical Trial for the treatment of Glioblastoma using PVS-RIPO. Long considered untreatable this brain cancer appears to have succumbed to T Cells genetically engineered with polio virus. The first cohort of patients is reported as having been disease free for three years.
"Currently, Phase I clinical trials of PVS-RIPO against recurrent glioblastoma brain tumors are ongoing at Duke. We plan to extend these studies (Phase II/III) in a quest to establish PVS-RIPO as a possible therapy for brain tumors. In addition, PVS-RIPO has the potential to work for other types of cancers. The reason for this is that the mechanisms responsible for PVS-RIPO’s effects against brain tumors broadly apply to almost all cancers"
This affects us because several major medical centers have introduced Clinical Trials of genetically modified T Cells targeting Prostate Cancer.
